<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220530055031N8</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-10-22</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Assessing a novel oral feeding strategy to prevent postoperative ileus</public_title>
      <acronym></acronym>
      <scientific_title>The impact of an innovative oral feeding approach on reducing ileus after elective open bowel surgeries: A comparison with traditional oral feeding</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>226</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/86849</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients were randomly assigned to either the control or intervention group using stratified randomization based on age, gender, BMI, and presence of major comorbidities to ensure balanced distribution of these key variables across groups. how is it possible, Blinding description: This was a single-blinded study. While both the participants and the nurse responsible for the data collection were aware of group assignments, the data analyst remained blinded to group allocation throughout the analysis process.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Postoperative ileus (POI) is a temporary impairment of bowel motility that commonly occurs after abdominal or colorectal surgery. It delays the return of normal gastrointestinal function, leading to abdominal distension, nausea, vomiting, intolerance to oral intake, and prolonged hospitalization. The study investigates strategies to reduce the duration and severity of postoperative ileus in patients undergoing elective open colorectal surgery..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients in the intervention group received standard perioperative, intraoperative, and postoperative care according to the ERAS protocol. However, postoperative oral feeding followed a structured regimen designed to stimulate early gut motility. Upon full recovery from anesthesia and stabilization of vital signs, oral intake was initiated as follows: •	First 12 hours: 15 mL of clear fluid every 15 minutes•	Next 12 hours: 15 mL every 10 minutes •	Following 24 hours: 15 mL every 5 minutes By 48 hours postoperatively, most patients were able to tolerate a full fluid diet. Solid food was introduced at 72 hours post-surgery. In cases where vomiting exceeded 100 mL within the first 24 hours, a nasogastric tube was reinserted, and oral feeding was temporarily paused. Intervention 2: Control group:  Patients in the control group received the Standard ERAS protocol, including early initiation of oral feeding after anesthesia recovery. However, unlike the intervention group, there was no standardized feeding schedule. The volume and timing of oral intake were determined by clinical judgement, based on individual patient tolerance.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Deidentified demographic data, surgical details, and postoperative outcome variables (e.g., duration of ileus, length of hospital stay).

When:
Within 6 months after publication and for up to 3 years thereafter.

To whom:
Deidentified data and related documents will be available to qualified researchers affiliated with academic or research institutions, upon reasonable request, for purposes of independent verification, meta-analysis, or secondary scientific analyses, provided that data sharing complies with ethical and institutional regulations.

Conditions:
The shared data and documents may be used only for research purposes that are scientifically valid, ethically approved, and consistent with the objectives of the original study. Researchers must provide a formal data-sharing request, including a brief proposal outlining the intended analyses, and obtain approval from the Ethics Committee of Tehran University of Medical Sciences before data access is granted.

Where to obtain:
Researchers may request data by contacting the corresponding investigator via email at [amiratashi@sina.tums.ac.ir]. Requests will be reviewed for scientific validity and compliance with ethical guidelines.

How to obtain:
Researchers may request data by contacting the corresponding investigator via email at [insert your email]. Requests will be reviewed for scientific validity and compliance with ethical guidelines.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyed Amir Miratashi Yazdi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sina Hospital, Hasan Abad Square , Imam Khomeini avenue, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>387611365</zip>
        <telephone>+98 21 6312 1267</telephone>
        <email>amiratashi@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyed Amir Miratashi Yazdi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sina Hospital, Hasan Abad Square , Imam Khomeini Avenue, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>387611365</zip>
        <telephone>+98 21 6312 1267</telephone>
        <email>amiratashi@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Adult patients aged 18 years or older.,
Patients scheduled for elective open colorectal surgery.
Patients with no pre-existing gastrointestinal motility disorders.
Patients with American Society of Anesthesiologists (ASA) physical status classification I–III.
Patients able to provide written informed consent</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who underwent emergency colorectal surgery (e.g., for bowel obstruction, perforation, or peritonitis).
Patients with a history of gastrointestinal motility disorders, such as gastroparesis, irritable bowel syndrome, or chronic constipation.
Patients with chronic opioid use for more than two weeks prior to surgery.
Patients who had major abdominal surgery within the previous six months.
Patients who experienced intraoperative complications requiring deviation from the standard ERAS protocol.
Patients requiring postoperative mechanical ventilation for more than 24 hours
Patients who were unable to initiate oral feeding within 24 hours after surgery.
Patients with cognitive impairments or language barriers that interfered with adherence to the feeding protocol.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients in the intervention group received standard perioperative, intraoperative, and postoperative care according to the ERAS protocol. However, postoperative oral feeding followed a structured regimen designed to stimulate early gut motility. Upon full recovery from anesthesia and stabilization of vital signs, oral intake was initiated as follows: •	First 12 hours: 15 mL of clear fluid every 15 minutes•	Next 12 hours: 15 mL every 10 minutes •	Following 24 hours: 15 mL every 5 minutes By 48 hours postoperatively, most patients were able to tolerate a full fluid diet. Solid food was introduced at 72 hours post-surgery. In cases where vomiting exceeded 100 mL within the first 24 hours, a nasogastric tube was reinserted, and oral feeding was temporarily paused</i_keyword>
      <i_keyword>Control group:  Patients in the control group received the Standard ERAS protocol, including early initiation of oral feeding after anesthesia recovery. However, unlike the intervention group, there was no standardized feeding schedule. The volume and timing of oral intake were determined by clinical judgement, based on individual patient tolerance.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Resolution of postoperative ileus (POI) was defined as the return of bowel sounds and first passage of gas or stool in the absence of abdominal distension or vomiting. The need for nasogastric tube reinsertion (in cases of vomiting exceeding 100 mL within the first 24 hours) was recorded as an indicator of feeding intolerance and persistence of ileus. Timepoint: Monitoring was performed continuously from recovery until discharge, with key assessment intervals corresponding to the oral feeding protocol at 0–12 hours, 12–24 hours, 24–48 hours, and 48–72 hours postoperatively (reflecting the initiation and progression of oral feeding). The time of first passage of gas or stool, return of bowel sounds, and initiation of the first solid diet were recorded daily until discharge. Method of measurement: Bedside clinical examination: Assessment of bowel sounds and evaluation of abdominal distension.Recording of clinical events by the nurse or clinical team, including the time of first passage of gas or stool, tolerance of oral diet, and the volume of vomiting (for determining the need for nasogastric tube reinsertion).Data extraction from patient medical records and case report forms (CRFs), followed by statistical analysis using SPSS software.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-10-14</approval_date>
        <contact_name>Ethic Committe of Tehran University of Medcial Science</contact_name>
        <contact_address>Tehran University of Medical Sciences, 16th Azar St., Enghelab Sq., Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
